Identifying Synthetic Lectins from a Competitive Screen for the Detection of Prostate Cancer

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• Prostate cancer detection and staging remain critical challenges in oncology.
• Synthetic lectins (SLs) offer potential as targeted diagnostic agents due to their specific binding properties.

Purpose of the Study:

• To develop and validate a screening method for identifying novel boronic acid-functionalized SLs selective for prostate cancer biomarkers.
• To evaluate the diagnostic accuracy of identified SLs in discriminating prostate cell lines based on cancer status and metastatic potential.

Main Methods:

• A dual dye competitive screening assay was employed using differentially labeled normal and cancerous prostate cell membrane extracts.
• Identified SLs were further analyzed in an array format to assess their ability to classify and discriminate various prostate cell lines.
• Selectivity against non-prostate cell lines was also evaluated.

Main Results:

• Five boronic acid-functionalized SLs selective for prostate-associated targets were identified.
• The SL array achieved 83% accuracy in classifying six prostate cell lines.
• The array demonstrated 96% accuracy in discriminating cell lines based on metastatic potential (healthy, low-metastatic, metastatic).
• Enhanced selectivity for prostate-derived cells over colon-derived cells was observed.

Conclusions:

• The developed screening method effectively identifies SLs with high specificity for prostate cancer targets.
• The focused SL array shows significant potential as a diagnostic tool for prostate cancer detection and staging.
• Further development could lead to improved non-invasive diagnostic strategies for prostate cancer.